OR WAIT null SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
A panel of ophthalmologists and optometrists discuss the significance of addressing dry eye disease using various types of treatment strategies, including pharmacologic and non-pharmacologic options.
April 30th 2021
A panel of ophthalmologists and optometrists begin a discussion on the management of dry eye disease by defining the condition and highlighting common symptoms.
The impact of autoimmune and systemic diseases as well as environmental triggers on the development of dry eye disease.
May 10th 2021
Eye care professionals explain the impact of unstable tear film and untreated dry eye disease on patient quality of life.
Criteria that would prompt further evaluation for dry eye disease and the types of tests used to work-up and accurately diagnose the condition.
May 17th 2021
Resources and strategies that can be used to help educate patients about dry eye disease and optimize adherence to therapy.
How to select and discuss sequential therapy with patients who have dry eye disease and set expectations for treatment.
May 24th 2021
Eye care professionals discuss their comfort in recommending oral omega-3 fatty acids to help treat dry eye disease.
The most common types of artificial tears recommended to help manage dry eye disease and the importance of proper use for full benefit.
June 1st 2021
Eye care specialists describe when corticosteroid therapy should be considered to treat dry eye disease and describe best practices when treating pre-surgical patients.
Types of in-office procedures currently being used by ophthalmologists and optometrists to aid in the treatment of dry eye disease.